Table 5.
Factors associated with an MRCI >37.5 12 months after kidney transplantation
| Characteristics | Crude model |
Adjusted model |
||||
|---|---|---|---|---|---|---|
| OR | [95% CI] | P value | OR | [95% CI] | P value | |
| Age at the time of kidney transplantation, yr | 1.03 | [1.01–1.05] | 0.001 | 1.01 | [0.99–1.03] | 0.47 |
| Body mass index, kg/m2 | 1.07 | [1.02–1.13] | 0.005 | 1.04 | [0.99–1.10] | 0.15 |
| Cardiovascular disease | ||||||
| No | 1 | |||||
| Yes | 1.90 | [1.23–2.94] | 0.004 | 1.46 | [0.91–2.34] | 0.12 |
| Dyslipidemia | ||||||
| No | 1 | |||||
| Yes | 2.90 | [1.87–4.52] | <0.001 | 2.01 | [1.23–3.27] | 0.005 |
| Diabetes | ||||||
| No | 1 | |||||
| Yes | 7.03 | [3.68–14.42] | <0.001 | 4.97 | [2.51–10.45] | <0.001 |
CI, confidence interval; MRCI, medication regimen complexity index; OR, odds ratio.
Sex, hypertension, and a history of cancer were tested in a univariate analysis but did not meet the criteria for inclusion in the multivariable analysis (P = 0.78, 0.83 and 0.14, respectively).